Consistent with the properties of the surviving CSCs in PDAC cells, following treatment with anti-cancer agents, one study reported the drastically increased expression of CSC markers in PDAC, including CD24 (47-fold increase) and CD44 (17-fold increase)39. This evidence concerns the gene CD44 and cancer.